BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36158664)

  • 1. Preoperative CT-based deep learning model for predicting overall survival in patients with high-grade serous ovarian cancer.
    Zheng Y; Wang F; Zhang W; Li Y; Yang B; Yang X; Dong T
    Front Oncol; 2022; 12():986089. PubMed ID: 36158664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep learning provides a new computed tomography-based prognostic biomarker for recurrence prediction in high-grade serous ovarian cancer.
    Wang S; Liu Z; Rong Y; Zhou B; Bai Y; Wei W; Wei W; Wang M; Guo Y; Tian J
    Radiother Oncol; 2019 Mar; 132():171-177. PubMed ID: 30392780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep Learning Provides a New Magnetic Resonance Imaging-Based Prognostic Biomarker for Recurrence Prediction in High-Grade Serous Ovarian Cancer.
    Liu L; Wan H; Liu L; Wang J; Tang Y; Cui S; Li Y
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Neoadjuvant Chemotherapy Response and High-Grade Serous Ovarian Cancer From CT Images in Ovarian Cancer with Multitask Deep Learning: A Multicenter Study.
    Yin R; Guo Y; Wang Y; Zhang Q; Dou Z; Wang Y; Qi L; Chen Y; Zhang C; Li H; Jian X; Ma W
    Acad Radiol; 2023 Sep; 30 Suppl 2():S192-S201. PubMed ID: 37336707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Development and Validation of a CT-Based Radiomics Nomogram to Preoperatively Predict Lymph Node Metastasis in High-Grade Serous Ovarian Cancer.
    Chen HZ; Wang XR; Zhao FM; Chen XJ; Li XS; Ning G; Guo YK
    Front Oncol; 2021; 11():711648. PubMed ID: 34532289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics Analysis of PET and CT Components of
    Wang X; Lu Z
    Front Oncol; 2021; 11():638124. PubMed ID: 33928029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study.
    Cui Y; Zhang J; Li Z; Wei K; Lei Y; Ren J; Wu L; Shi Z; Meng X; Yang X; Gao X
    EClinicalMedicine; 2022 Apr; 46():101348. PubMed ID: 35340629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CT-based radiomics nomogram for predicting early recurrence in patients with high-grade serous ovarian cancer.
    Chen HZ; Wang XR; Zhao FM; Chen XJ; Li XS; Ning G; Guo YK
    Eur J Radiol; 2021 Dec; 145():110018. PubMed ID: 34773830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel prognostic nomograms to assess survival in high-grade serous ovarian carcinoma after surgery and chemotherapy: a retrospective cohort study from SEER database.
    Huang W; Bao Y; Luo X; Yao L; Yuan L
    Ann Transl Med; 2022 Jul; 10(13):728. PubMed ID: 35957727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of an Immune-Related Gene-Pair Model of High-Grade Serous Ovarian Cancer After Platinum-Based Chemotherapy.
    Lin J; Xu X; Sun D; Li T
    Front Oncol; 2020; 10():626555. PubMed ID: 33680950
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Xue XQ; Yu WJ; Shi X; Shao XL; Wang YT
    Front Oncol; 2022; 12():911168. PubMed ID: 36003788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer.
    Zhu T; Chen R; Wang J; Yue H; Lu X; Li J
    Cancer Cell Int; 2020; 20():257. PubMed ID: 32565741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative CT-based Deep Learning Model for Predicting Disease-Free Survival in Patients with Lung Adenocarcinomas.
    Kim H; Goo JM; Lee KH; Kim YT; Park CM
    Radiology; 2020 Jul; 296(1):216-224. PubMed ID: 32396042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy.
    Miller KR; Patel JN; Zhang Q; Norris EJ; Symanowski J; Michener C; Sehouli J; Braicu I; Destephanis DD; Sutker AP; Jones W; Livasy CA; Biscotti C; Ganapathi RN; Tait DL; Ganapathi MK
    Gynecol Oncol; 2018 Apr; 149(1):155-162. PubMed ID: 29402501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Nomogram Combining MRI Multisequence Radiomics and Clinical Factors for Predicting Recurrence of High-Grade Serous Ovarian Carcinoma.
    Li C; Wang H; Chen Y; Fang M; Zhu C; Gao Y; Li J; Dong J; Wu X
    J Oncol; 2022; 2022():1716268. PubMed ID: 35571486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study.
    Jiang Y; Zhang Z; Yuan Q; Wang W; Wang H; Li T; Huang W; Xie J; Chen C; Sun Z; Yu J; Xu Y; Poultsides GA; Xing L; Zhou Z; Li G; Li R
    Lancet Digit Health; 2022 May; 4(5):e340-e350. PubMed ID: 35461691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of histopathological images and multi-dimensional omics analyses predicts molecular features and prognosis in high-grade serous ovarian cancer.
    Zeng H; Chen L; Zhang M; Luo Y; Ma X
    Gynecol Oncol; 2021 Oct; 163(1):171-180. PubMed ID: 34275655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of MRI-Based Radiomics Model to Predict the Risk of Recurrence in Patients With Advanced High-Grade Serous Ovarian Carcinoma.
    Li HM; Gong J; Li RM; Xiao ZB; Qiang JW; Peng WJ; Gu YJ
    AJR Am J Roentgenol; 2021 Sep; 217(3):664-675. PubMed ID: 34259544
    [No Abstract]   [Full Text] [Related]  

  • 20. An integrated nomogram combining deep learning, Prostate Imaging-Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study.
    Hiremath A; Shiradkar R; Fu P; Mahran A; Rastinehad AR; Tewari A; Tirumani SH; Purysko A; Ponsky L; Madabhushi A
    Lancet Digit Health; 2021 Jul; 3(7):e445-e454. PubMed ID: 34167765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.